GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IMBDX 461030.KQ · KRW

N/A · KOSDAQ · 🇰🇷 South Korea

Compare

2,325

-2.72%

Close of 5 Nov 2026, in KRW

Price performance

Chart by TradingView, with its own licensed prices

IMBDX — daily KRX:461030

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View IMBDX on TradingView ↗
Market value
₩31.13bn
Last close × shares
Volume
18.1k
Shares, 5 Nov 2026

About IMBDX

Its shares trade on KOSDAQ under the ticker 461030.KQ. It has been listed since 3 April 2024. In the fiscal year to 31 December 2025, it reported revenue of ₩5.33bn and a net loss of ₩7.93bn. At that date it held total assets of ₩27.12bn and shareholders' equity of ₩25.16bn.

IMBDX Inc is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-04-03. IMBDX Inc is a Korea-based company principally engaged in the provision of laboratory analysis services. The firm is principally engaged in the provision of laboratory analysis services such as clinical diagnosis services and genetic analysis services based on liquid biopsy technology. In addition, the Company is also engaged in the development, manufacture and sale of diagnostic products.

Figures and description from our data supplier, not checked against the company's own report.

More about IMBDX →

Latest on IMBDX

Our reporting

We have not reported on IMBDX yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is IMBDX's ticker?

IMBDX trades as 461030.KQ on KOSDAQ, under ISIN KR7461030009.

What was IMBDX's last closing price?

2,325 on 5 Nov 2026. The figure is in KRW and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.